Publications by authors named "Massimo Ferraro"

Claim this Profile
C
Clinical safety and performance of the third-generation Fantom Encore sirolimus-eluting bioresorbable scaffold: Insights from a single-center study.
Francesco Amata, Massimo Ferraro, Antonio Mangieri, Damiano Regazzoli, Giuseppe Ferrante

Cardiovasc Revasc Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years.
Alessandro Sticchi, Concetta Tatali, Massimo Ferraro, Arif A Khokhar, Alessandra Scoccia

J Clin Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepancies in vessel sizing between angiography and intravascular ultrasound varies according to the vessel evaluated.
Kensuke Takagi, Joanne Shannon, Sandeep Basavarajaiah, Azeem Latib, Rasha Al-Lamee, Massimo Ferraro

Int J Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score.
Robert T Gerber, Alfonso Ielasi, Rasha Al-Lamee, Azeem Latib, Flavio Airoldi, Massimo Ferraro

Cardiovasc Revasc Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation.
Rasha Al-Lamee, Alfonso Ielasi, Azeem Latib, Cosmo Godino, Massimo Ferraro

JACC Cardiovasc Interv· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.
Rasha Al-Lamee, Alfonso Ielasi, Azeem Latib, Cosmo Godino, Massimo Ferraro

Am J Cardiol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Alaide Chieffo, Valeria Magni, Azeem Latib, Francesco Maisano, Alfonso Ielasi, Massimo Ferraro

JACC Cardiovasc Interv· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient.
Ioannis Iakovou, Giuseppe M Sangiorgi, Goran Stankovic, Nicola Corvaja, Giancarlo Vitrella, Massimo Ferraro

Catheter Cardiovasc Interv· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results.
Dejan Orlic, Erminio Bonizzoni, Goran Stankovic, Flavio Airoldi, Alaide Chieffo, Massimo Ferraro

J Am Coll Cardiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary stent implantation throughout technical evolution: immediate and follow-up results.
Leo Finci, Massimo Ferraro, Yoshio Kobayashi, Joseph de Gregorio Jd, Issam Moussa

Int J Cardiovasc Intervent· January 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis